Retroviral protease inhibiting compounds

Details Retroviral protease inhibiting compounds Retroviral protease inhibiting compounds

2007-10-09

2007-10-09

O'Sullivan, Peter (Department: 1621)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C540S460000, C540S488000, C540S492000, C544S088000, C544S097000, C544S316000, C544S332000, C548S229000, C548S233000, C548S331500, C548S550000, C546S233000, C514S212030, C514S331000, C514S428000

Reexamination Certificate

active

10280652

ABSTRACT:
A compound of the formula:is disclosed as an HIV protease inhibitor. Methods and compositions for inhibiting an HIV infection are also disclosed.

REFERENCES:
patent: 4221789 (1980-09-01), Rodriguez et al.
patent: 4448816 (1984-05-01), Barsa et al.
patent: 4885292 (1989-12-01), Ryono et al.
patent: 5142056 (1992-08-01), Kempf et al.
patent: 5164388 (1992-11-01), De et al.
patent: 5196438 (1993-03-01), Martin et al.
patent: 5354866 (1994-10-01), Kempf et al.
patent: 5413999 (1995-05-01), Vacca et al.
patent: 5484926 (1996-01-01), Dressman et al.
patent: 5541206 (1996-07-01), Kempf et al.
patent: 5635523 (1997-06-01), Kempf et al.
patent: 5643878 (1997-07-01), Bold et al.
patent: 5648497 (1997-07-01), Kempf et al.
patent: 5674882 (1997-10-01), Kempf et al.
patent: 5750648 (1998-05-01), Chang et al.
patent: 5770573 (1998-06-01), Arrhenius et al.
patent: 5834401 (1998-11-01), Kawamura et al.
patent: 5846987 (1998-12-01), Kempf et al.
patent: 5883252 (1999-03-01), Tung et al.
patent: 5886036 (1999-03-01), Kempf et al.
patent: 5905082 (1999-05-01), Roberts et al.
patent: 5914332 (1999-06-01), Sham et al.
patent: 5945413 (1999-08-01), Tung et al.
patent: 5977027 (1999-11-01), Kawamura et al.
patent: 6017928 (2000-01-01), Kempf et al.
patent: 6037157 (2000-03-01), Norbeck et al.
patent: 6613764 (2003-09-01), Randad et al.
patent: 0005689 (1979-11-01), None
patent: 0342541 (1989-11-01), None
patent: 0365992 (1990-05-01), None
patent: 0428849 (1991-05-01), None
patent: 0 486 948 (1992-05-01), None
patent: 0490667 (1992-06-01), None
patent: 0532466 (1993-03-01), None
patent: 0560268 (1993-09-01), None
patent: 0580402 (1994-01-01), None
patent: 0747352 (1996-11-01), None
patent: 2 773 994 (1998-01-01), None
patent: 8910752 (1989-11-01), None
patent: 9208701 (1992-05-01), None
patent: 9307128 (1993-04-01), None
patent: 9323368 (1993-11-01), None
patent: 94/06775 (1994-03-01), None
patent: 9405639 (1994-03-01), None
patent: 94/14436 (1994-07-01), None
patent: 95/07696 (1995-03-01), None
patent: 95/09614 (1995-04-01), None
patent: 95/20384 (1995-08-01), None
patent: 9530670 (1995-11-01), None
patent: 9605180 (1996-02-01), None
patent: 97/17180 (1997-07-01), None
patent: 9721685 (1998-06-01), None
Randad et al, Chemical Abtracts, vol. 133:105345, 2000.
Y. Becker, et al., “Asymmetric Hydroformylation and Hydrocarboxylation of Enamides. Synthesis of Alanine and Proline”, J. Org. Chem vol. 45, pp. 2145-2151 (1980).
H. Takechi, et al., Photoreactions of Succinimides with an N-Acyl Group in the Side Chain. Synthesis and Stereochemistry of Tricyclic Pryrrolo[1,2-a] pyrazine Ring Systems), Chem. Pharm. Bull. vol. 34 (8) 3142-3152)(1986).
A. Smith, et al., “Pyrrolinone-Based HIV Protease Inhibitors. Design, Synthesis, and Antiviral Activity: Evidence for Improved Transport”, J. Am. Chem. Soc. 1995 117, 11113-11123.
J. Vacca, et al., “Conformationally Constrained HIV-1 Protease Inhibitors”, Bioorganic & Medicinal Chem. Letters, vol. 4, No. 3, pp. 499-504 (1994).
R. Randad, “De Novo Design of Nonpeptidic HIV-1 Protease Inhibitors: Incorporation of Structural Water”, Bioorganic & Med. Chem. Let, vol. 4, No. 10, pp. 1247-1252 (1994).
D. Scholz, “Inhibitors of HIV-1 Proteinase Containing 2-Heterosubstituted 4-Amino-3-hydroxy-5-phenylpentanoic Acid: Synthesis, Enzyme Inhibition, and Antiviral Activity”, J. Med. Chem. (1994) vol. 37, No. 19, pp. 3079-3089.
J. Jindrich, “Synthesis of N-(3-Fluoro-2-Phosphonomethoxypropyl) (FPMP) Derivates of Heterocyclic Bases”, Collect. Czech.Chem. Commun. vol. 58 (7) 1645-1667 (1993).
Chen, “Expression and Activity-Dependent Changes of a Novel LimBic-Serine Protease Gene in the Hippocampus”, J of Neuroscience, Jul. '95 vol. 15 (7), pp. 5088-50977.
Kempf, D.J., “Design of Orally Bioavailable, Symmetry-Based Inhibitors of HIV Protease”, BIOORG. Med. Chem., vol. 2, No. 9, 1994, pgs. 847-858, USA and Chen. Abs., vol. 122, No. 19, p. 1134, (1995).
Kempf, et al, “Peptide Derivatives Preparation as Retroviral Protease Inhibitors”, Chem, Abstracts, v114, No. 25, p. 374 (1991).
Kumar, G.N., “Potent inhibition of the cytochrome p.-405 3A-mediated human liver microsomal metabolism of a novel HIV protease inhibitor by ritonavir, a positive drug-drug interaction”, Drug Metab. Dispos., vol. 27(8), pp. 902-908, (1999).
J. Rudinger, Peptide Hormones (Ed...J A Parson, Jun. 1976: Univ. Park Press), pp. 1-6.
Stone, “Biology Approaches the Teraflop Era”, Science, v256, p. 440-442.
Stoner et al. “Synthesis of ABT-378, an HIV Protease Inhibitor Candidate: Avoiding the Use of Carbodiimides in a Dufficult Peptide Coupling”Organic Process Research&Developmentvol. 3(2): 145-148 (1999).
Stoner et al. “Synthesis of HIV Portease Inhibitor ABT-378 (Lopinavir)”Organic Process Research&Developmentvol. 4(4):264-269 (2000).

Affiliated with

Also associated with

Rating

Retroviral protease inhibiting compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Retroviral protease inhibiting compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Retroviral protease inhibiting compounds will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3900795